Sponsor pipeline

ARCE Therapeutics, Inc. clinical trial pipeline

Get alerts when ARCE Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06680752 Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS Acute Myeloid Leukemia, in Relapse Recruiting 2025-12-10
Not specified
NCT06906380 A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies Acute Myeloid Leukemia, in Relapse Not Yet Recruiting 2025-12-08

Disease areas by active trials

Acute Myeloid Leukemia (AML) (2) · Leukemia (2) · Myelodysplastic Syndromes (MDS) (2)

Get alerts when ARCE Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free